Novelli S, Lécuroux C, Goujard C, Reynes J, Villemant A, Blum
L, Essat A, Avettand-Fenoël V, Launay O, Molina JM, Bourgeois C, Meyer
L. Persistence of monocyte activation under treatment in people
followed since acute HIV-1 infection relative to participants at high
or low risk of HIV infection. EBioMedicine. 2020 Nov 25. Lien PubMed
Bauer R, Netzer E, Pintado C, Capitant C, Cua E, Etien N,
Fonsart J, Pialoux G, Chidiac C, Etienne C, Doré V, Meyer L, Molina JM. Coverage
of sex acts by event-driven pre-exposure prophylaxis – A sub-study of
the ANRS IPERGAY Trial"; AIDS Behav. 2020 Nov 24. Lien PubMed
Di Ciaccio M, Sagaon-Teyssier L, Mimi M, Suzan-Monti M,
Protière C, Rojas Castro D, Meyer L, Tremblay C, Chidiac C, Capitant C,
Préau M, Molina JM, Spire B. Changes in sexual behaviors in men
who have sex with men: a comparison between the double-blind and
open-label extension phases of the ANRS-IPERGAY trial; AIDS Behav. 2020
Nov 24. Lien PubMed
Freguja R, Bamford A, Zanchetta M, Del Bianco P, Giaquinto C,
Harper L, Dalzini A, Cressey TR, Compagnucci A, Saidi Y, Riault Y, Ford
D, Gibb D, Klein N, De Rossi A; Paediatric European Network for
Treatment of AIDS (PENTA) 11 Trial Team. Long-term clinical,
virological and immunological outcomes following planned treatment
interruption in HIV-infected children. HIV Med. 2020 Oct 29.Lien PubMed
Pauline D J Bollen, Cecilia L Moore, Hilda A Mujuru, Shafic
Makumbi, Adeodata R Kekitiinwa, Elisabeth Kaudha, Anna Parker, Godfrey
Musoro, Annet Nanduudu, Abbas Lugemwa, Pauline Amuge, James G Hakim,
Pablo Rojo, Carlo Giaquinto, Angela Colbers, Diana M Gibb, Deborah Ford,
Anna Turkova, David M Burger, and the ODYSSEY trial team. Simplified dolutegravir dosing for children with HIV weighing 20 kg or
more: pharmacokinetic and safety substudies of the multicentre,
randomised ODYSSEY trial. Lancet HIV . 2020 Aug.Lien PubMed
Di Ciaccio M, Fressard L, Sagaon-Teyssier L, Protiere C,
Gatey C, Chas J, Cotte L, Castro DR, Meyer L, Molina JM, Préau M, Spire
B. What are the situational and behavioral factors associated
with condomless anal sex without PrEP in men who have sex with men?
Results from the ANRS-IPERGAY trial. AIDS. 2020 Apr 13. Lien PubMed
Segeral O, Dim B, Durier C, Prak S, Chhim K , Vong C, Pech S, Tiv S , Nem B, Hout K, Nouhin J, Chhun S, Borand L. HBeAg
rapid test and alanine aminotransferase level-based algorithm to
identify pregnant women at risk of HBV mother-to-child transmission: the
ANRS 12345 TA PROHM study. Clin Infect Dis. 2020 Mar 19. Lien PubMed
Lutsar I, Chazallon C, Trafojer U, Meiffréddy de Cabre V,
Auriti C, Bertaina C, Calo Carducci FI, Canpolat FE, Esposito S,
Fournier I, Hallik M, Metsvaht T, Mitsiakos G, Pana ZD, Mosca F, Pugni
L, Roilides E, Rossi P, Srafidis K, Sanchez L, Sharland M, Usonis V,
Warris A, Aboulker JP, Giaquinto C and on behalf of NeoMero Consortium. Meropenem vs standard of care for treatment of neonatal late onset sepsis (NeoMero1): a randomised controlled trial. PLOS ONE 2020 Mar 4. Lien PubMed
Liegeon G, Antoni G, Pialoux G, Capitant C, Cotte L, Charreau
I, Tremblay C, Cua E, Senneville E, Raffi F, Meyer L, Molina JM,
ANRS-IPERGAY study group. Changes in Kidney Function Among High
Risk Gay Men Initiating on Demand Tenofovir Disoproxil Fumarate -
Emtricitabine in Prophylaxis of HIV Infection in the ANRS IPERGAY Study.
JIAS. 2020 Feb 23. Lien PubMed
Cotte L, Veyer D, Charreau I, Péré H, Cua E, Carette D, Chas
J, Capitant C, Chidiac C, Fléjou JF, Fouéré S, Heard I, Meyer L, Puech
J, Tremblay C, Delaugerre C, Molina JM. Prevalence and
incidence of HPV infection in men having sex with men enrolled in a PrEP
study: A sub-study of the ANRS IPERGAY trial. Clin Inf Dis. 2020 Jan 7. Lien PubMed
Gras J, Mahjoub N, Charreau I, Cotte L, Tremblay C, Chas J,
Raffi F, Cua E, Guillon B, Guigue N, Chaix ML, Meyer L, Molina JM,
Delaugerre C; and the Ipergay study group. Early diagnosis and
risk factors of acute hepatitis c in high-risk men who have sex with men
on pre-exposure prophylaxis. AIDS. 2020 Jan 1. Lien PubMed